GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Indinavir

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Return to full drug recordRead selected sourcesHow to use this review

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Source-content exception: the live original page is empty apart from its heading. This does not establish a no-adjustment recommendation.

The separate CRIXIVAN label summary supplies actual historical dosing. It is not presented as missing text recovered from the original GlobalRPh page.

Check source scope before reading a dose

Renal Drug Handbook, fifth edition

Product / population
Historical 2019 reference; renal bands retain the book's own method labels.
Renal method
Not specified
Source revision
Not established
Retrieved
2026-09-05
Local review status
Historical handbook facts locally summarized; not a current U.S. label or a modern CRRT protocol.
Handbook

Renal Drug Handbook, fifth edition

UK Renal Pharmacy Group / Ashley and Dunleavy / CRC Press · Historical 2019 reference; renal bands retain the book's own method labels.

Renal method: Not specified in this summary.
Source date: Not established
Retrieved: 2026-09-05

Historical handbook facts locally summarized; not a current U.S. label or a modern CRRT protocol.

Historical renal guidance

The 20-50, 10-20 and <10 mL/min bands retain normal dosing with close monitoring. APD/CAPD, HD and high-flux HDF refer to <10; CAV/VVHD refers to 10-20. The book describes removal as unlikely with APD/CAPD and CAV/VVHD and absent with HD/high-flux HDF.

indinavir:rdh5-521-522-1 · Source locator: Printed page 521: renal impairment and renal replacement

Stone-related caution

The handbook discusses crystalluria and nephrolithiasis, including temporary interruption for 1-3 days when flank pain occurs, with or without hematuria.

indinavir:rdh5-521-522-2 · Source locator: Printed page 522: Other information

Source-specific limits

The archived U.S. label states that HD/PD removal is unknown, whereas the book uses more definite dialyzability categories. Preserve this disagreement. This entry is retained from the mandatory GlobalRPh baseline and is not classified as a currently marketed new U.S. drug.

Source identity and provenance
Retrieved
2026-09-05
Handbook page
Printed page 521-522; PDF page 540-541
Hash meaning
Locally authored source summary, not original SPL/XML/PDF bytes
Local summary SHA-256
eb8f5d8b190957cd715cde0e4c333d8ef37cf79dd929e04a73ae94caa0e5202b

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=indinavir&s1=rdh5-521-522&h1=a8c488623059d764f014bcba1eb21aa75789e15f72494ab9be84a8708de99a6c